Amit Munshi

Mr. Amit D.
Munshi is a Chairman at Sensorion SA, an Independent Chairman at Inhibikase Therapeutics, Inc., a Chairman at Zura Bio Ltd. and a Co-Chairman at Enterprise Therapeutics Ltd. He is on the Board of Directors at Arcutis Biotherapeutics, Inc., Adrista, Inc., Onebiopharma, Inc. and Pulmatrix Operating Co., Inc. Mr. Munshi was previously employed as a Chief Executive Officer & Director by Orna Therapeutics, Inc., a Chief Executive Officer & Director by ReNAgade Therapeutics, Inc., an Independent Director by Social Capital Suvretta Holdings Corp.
IV, an Independent Director by Damora Therapeutics, Inc., an Independent Director by Pulmatrix, Inc., a President & Chief Executive Officer by Arena Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Zalicus, Inc., a President, Chief Executive Officer & Director by EPIRUS Biopharmaceuticals, Inc., a Chief Executive Officer by EPIRUS Biopharmaceuticals, Inc. /Old/, a President & Chief Executive Officer by Percivia LLC, a Chief Business Officer by Kythera Biopharmaceuticals Inc, a General Manager-Nephrology Europe by Amgen, Inc., a Chairman-Management Board by Arena Pharmaceuticals GmbH, a Principal by Astra Merck, Inc., a Chairman by Cytrellis Biosystems, Inc., a Principal by Iolab Corp., and a Chief Business Officer by Johnson & Johnson.
He also served on the board at Oxeia Biopharmaceuticals, Inc., LungLife AI, Inc., JATT Acquisition Corp.
and Nephrian, Inc. He received his undergraduate degree from the University of California, Riverside and an MBA from Peter F Drucker & Masatoshi Ito Graduate School of Management.